“Neuregulin-4 (Nrg-4) As a Metabolic Regulator: A Comprehensive Review of Its Association With Dyslipidemia and Liver Function Abnormalities in Newly Diagnosed Type 2 Diabetes Mellitus”. 2025. Vascular and Endovascular Review 8 (19s): 177-81. https://doi.org/10.64149/J.Ver.8.19s.177-181.